Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Selexys Pharmaceuticals
840 Research Parkway, Suite 510
Oklahoma City, OK 73104
Phone: 405-319-8195
http://www.selexys.com

Selexys Pharmaceuticals, Corp., is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. Selexys is also developing an antibody directed against PSGL-1 for the treatment of Crohn's disease, multiple myeloma, and other inflammatory disorders.

Key Contact
Name
Scott Rollins, Ph.D.
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/19/12 $23,000,000 Series A MPM Capital
undisclosed


Featured Reading